BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32650849)

  • 1. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
    Bartenjev MS; Isaković-Vidović S; Bartenjev I
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should topical imiquimod be used for positive margins in lentigo maligna?
    Wang TS; Griffiths CC; Roman EM
    J Am Acad Dermatol; 2021 Aug; 85(2):521-522. PubMed ID: 32387661
    [No Abstract]   [Full Text] [Related]  

  • 3. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periocular lentigo maligna treated with imiquimod.
    O'Neill J; Ayers D; Kenealy J
    J Dermatolog Treat; 2011 Apr; 22(2):109-12. PubMed ID: 20666668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentigo maligna successfully treated with imiquimod.
    du Plessis PJ
    S Afr J Surg; 2007 May; 45(2):72. PubMed ID: 17674567
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
    Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
    Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lentigo maligna with imiquimod 5% cream.
    Hopson B; Richey D; Sajben FP
    J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Melanocyte Density Counts in Topical Imiquimod-Treated Skin Surrounding Lentigo Maligna vs Control Biopsy Specimens.
    Flores S; Luby NJ; Bowen GM
    JAMA Dermatol; 2018 Apr; 154(4):482-484. PubMed ID: 29453870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
    Woodmansee CS; McCall MW
    Dermatol Surg; 2009 Aug; 35(8):1286-9. PubMed ID: 19438661
    [No Abstract]   [Full Text] [Related]  

  • 11. Rate of recurrence following treatment of lentigo maligna with carbon dioxide laser alone or in combination with imiquimod: Results of a long-term study.
    Kaur A; Javed MU; Venables B; Murison M; Yarrow J
    J Plast Reconstr Aesthet Surg; 2023 Oct; 85():95-97. PubMed ID: 37473646
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
    van Meurs T; van Doorn R; Kirtschig G
    Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
    [No Abstract]   [Full Text] [Related]  

  • 13. [Imiquimod in the treatment of lentigo maligna].
    Nagore E; Botella-Estrada R
    Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
    [No Abstract]   [Full Text] [Related]  

  • 14. Lentigo maligna treated with topical imiquimod: dermatoscopy usefulness in clinical monitoring.
    Costa MC; Abraham LS; Barcaui C
    An Bras Dermatol; 2011; 86(4):792-4. PubMed ID: 21987152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek].
    Cheikhrouhou H; Pouaha J; Claeys A; Truchetet F
    Ann Dermatol Venereol; 2010 Feb; 137(2):142-4. PubMed ID: 20171439
    [No Abstract]   [Full Text] [Related]  

  • 16. Amelanotic lentigo maligna managed with topical imiquimod.
    Lapresta A; García-Almagro D; Sejas AG
    J Dermatol; 2012 May; 39(5):503-5. PubMed ID: 21973079
    [No Abstract]   [Full Text] [Related]  

  • 17. Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases.
    de Troya-Martín M; Frieyro-Elicegui M; Fúnez Liébana R; Aguilar Bernier M; Fernández-Canedo NI; Blázquez Sánchez N
    Dermatol Surg; 2008 Nov; 34(11):1561-6. PubMed ID: 18798748
    [No Abstract]   [Full Text] [Related]  

  • 18. Imiquimod: a novel treatment for lentigo maligna.
    Ahmed I; Berth-Jones J
    Br J Dermatol; 2000 Oct; 143(4):843-5. PubMed ID: 11069469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical imiquimod for periocular lentigo maligna.
    Demirci H; Shields CL; Bianciotto CG; Shields JA
    Ophthalmology; 2010 Dec; 117(12):2424-9. PubMed ID: 20591492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation.
    Kupfer-Bessaguet I; Guillet G; Misery L; Carre JL; Leroy JP; Sassolas B
    J Am Acad Dermatol; 2004 Oct; 51(4):635-9. PubMed ID: 15389205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.